[1]
Omar Khan, O. 2026. Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis. EXCLI Journal. 25, (Jan. 2026), 310–329. DOI:https://doi.org/10.17179/excli2025-9096.